AB SCIEX QTRAP¿ 4500MD LC/MS/MS System Mass Spectrometer for In-Vitro Diagnostic Use. Instrume...

FDA Device Recall #Z-2529-2016 — Class II — June 16, 2016

Recall Summary

Recall Number Z-2529-2016
Classification Class II — Moderate risk
Date Initiated June 16, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Ab Sciex
Location Framingham, MA
Product Type Devices
Quantity 28 units

Product Description

AB SCIEX QTRAP¿ 4500MD LC/MS/MS System Mass Spectrometer for In-Vitro Diagnostic Use. Instrument Part Number (REF): 5031231 3200MD series and 4500MD series are mass spectrometers intended to identify inorganic or organic compounds (e.g., lead, mercury, and drugs) in human specimens by ionizing the compound under investigation and separating the resulting ions by means of an electrical and magnetic field according to their mass. It is intended for in vitro diagnostic purposes. For in vitro diagnostic use.

Reason for Recall

MultiQuant MD software where under certain conditions a user can be presented with incorrect quantitative results when using the Sum Multiple Ions feature.

Distribution Pattern

Worldwide Distribution - US (Nationwide) Internationally to Canada, Austria, China, Netherlands, Norway, India, Korea, Germany, France, Switzerland, Ireland, Italy, Singapore, Russia, UK, Malaysia,

Lot / Code Information

Software Version: MultiQuant MD 3.0, MultiQuant MD 3.0.1 and MultiQuant MD 3.0.2 software

Other Recalls from Ab Sciex

Recall # Classification Product Date
Z-0175-2022 Class II Cliquid MD version 3.4 software used in conjunc... Oct 4, 2021
Z-2526-2016 Class II AB Sciex API 3200MD" LC/MS/MS System. In-Vitro ... Jun 16, 2016
Z-2527-2016 Class II AB SCIEX 3200MD QTRAP¿ LC/MS/MS System Mass Sp... Jun 16, 2016
Z-2528-2016 Class II AB SCIEX Triple Quad 4500MD LC/MS/MS System. M... Jun 16, 2016
Z-1671-2016 Class II AB Sciex Triple Quad 4500MD LC/MS/MS System, Pa... Mar 25, 2016

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.